Recent DOC Stock Price | DOC Stock Predictions | |
$21.78 | +13.50% |
$24.72 |
Recent DOC Analyst Ratings Breakdown, Making DOC Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 11 | 11 | 11 | 11 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 7 | 7 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.79 | 1.79 | 1.65 | 1.65 |
For the DOC stock predictions from the analysts covering Healthpeak Properties Inc, we have collected all of the individual DOC stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 16 different analysts covering DOC (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DOC stock predictions may vary widely, another useful metric to consider is the median DOC stock prediction, which represents the price at which half of the analysts
made DOC stock predictions that were higher and half made DOC stock predictions that were lower. This makes for a different take on the DOC stock predictions out there, as compared to average or mean.
And that median across all the individual DOC stock predictions was: $24.5 as of 2024-10-10.
The very highest of the DOC stock predictions for one year price target was $33.0, while the very lowest of the DOC stock predictions in the analyst group was
$20.0 (with a standard deviation of $2.966). Get the latest Zacks research report on DOC — FREE
Find out: DOC next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
TRVI Stock Predictions
SRAX Stock Predictions
GFI Stock Predictions
GES Stock Predictions
VRNS Stock Predictions
BRMK Stock Predictions
SLB Stock Predictions
PFSI Stock Predictions
THG Stock Predictions
|
DOC Next Dividend Date » (Projection based upon history) DOC Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (3.21 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |